|
Rheumatology
Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: a 35-years of experience at a single center
Howook Jeon, Jennifer Lee, Su-Jin Moon, Seung-Ki Kwok, Ji Hyeon Ju, Wan-Uk Kim, Sung-Hwan Park
Korean J Intern Med. 2024;39(2):347-359. Published online January 22, 2024
Background/Aims: Renal relapse has known to be a poor prognostic factor in patients with lupus nephritis (LN), but there were few studies that identified the risk factors of renal relapse in real world. We conducted this study based on 35-years of experience at a single center to find out predictors..
|
|
|
Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea
Kyung Min Ko, Su-Jin Moon
Korean J Intern Med. 2023;38(1):113-124. Published online August 20, 2021
Background/Aims: This study aims to evaluate the incidence of malignancy in patients with rheumatoid arthritis (RA) and to investigate risk factors for such in a nationwide, population-based cohort.
Methods: In a large, prospective, observational cohort study, 5,077 patients with RA were enrolled f..
|
|
|
Engagement of Toll-Like Receptor 3 Induces Vascular Endothelial Growth Factor and Interleukin-8 in Human Rheumatoid Synovial Fibroblasts
Su-Jin Moon, Mi-Kyung Park, Hye-Jwa Oh, Seon-Yeong Lee, Seung-Ki Kwok, Mi-La Cho, Ji Hyeon Ju, Kyung-Su Park, Ho-Youn Kim, Sung-Hwan Park
Korean J Intern Med. 2010;25(4):429-435. Published online November 27, 2010
Background/AimsAngiogenesis, which is a critical step in the initiation and progression of rheumatoid arthritis (RA), involves pro-angiogenic factors, including interleukin (IL)-8 and vascular endothelial growth factor (VEGF). We investigated the role of Toll-like receptor 3 (..
|
|
|
Hemorrhagic pericarditis with cardiac tamponade after percutaneous coronary intervention associated with the use of abciximab
Su-Jin Moon, Hee-Jeoung Yoon, Sung-Ho Her, Jong-Min Lee, Ho-Jung An, Yune-Jeong Lee, Seung-Won Jin
Korean J Intern Med. 2008;23(3):156-160. Published online September 20, 2008
Glycoprotein (GP) IIb/IIIa inhibitors, such as abciximab, are used as adjunctive therapy for percutaneous coronary intervention (PCI) in high-risk non-ST-elevation myocardial infarction (NSTEMI) and in ST-elevation myocardial infarction (STEMI), although their effects when used for STEMI are less..
|
|
|
The Association Between Current Helicobacter pylori Infection and Coronary Artery Disease
Seung-Won Jin, Sung-Ho Her, Jong-Min Lee, Hee-Jeoung Yoon, Su-Jin Moon, Pum-Joon Kim, Sang-Hong Baek, Ki-Bae Seung, Jae-Hyung Kim, Sang-Bum Kang, Jae-Hi Kim, Keon-Yeop, Kim
Korean J Intern Med. 2007;22(3):152-156. Published online September 30, 2007
BackgroundThe role of Helicobacter pylori (H. pylori) in the pathogenesis of coronary artery disease (CAD) is still controversial, and the relation between current H. pylori infection and CAD has not been fully examined. This ..
|
|
|
